Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer. Janjigian YY, Al-Batran SE, Wainberg ZA, Muro K, et al. N Engl J Med 2025;393:217-230.

Read + Share

Amedeo Smart

Independent Medical Education

Janjigian YY, Al-Batran SE, Wainberg ZA, Muro K, et al. Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer. N Engl J Med 2025;393:217-230.
PMID: 40454643